文献速递艾滋病与性传播感染

HIV-1 F亚型整合酶催化核心结构域外的多态性在整合酶抑制剂耐药突变Q148H背景下导致复制能力严重丧失

HIV-1 subtype F integrase polymorphisms external to the catalytic core domain contribute to severe loss of replication capacity in context of the integrase inhibitor resistance mutation Q148H.
PubMed 文献 · J Antimicrob Chemother · 2022-01-01

研究比较B亚型与F亚型整合酶在Q148H(±G140S)耐药突变下的复制与整合能力。F1(BF)重组整合酶Q148H突变株p24低或不可测,整合DNA减少9至16000倍,而NL4-3-Q148H仅减少5倍;互换催化核心结构域片段未能挽救复制缺陷。结论认为F亚型整合酶背景下的功能损伤解释了该通路在体内未被选择。

要点

  • F1(BF)整合酶Q148H突变株第15天p24低(10²-10⁴ pg/mL)或不可测,B亚型NL4-3-Q148H为10⁵-10⁶ pg/mL。
  • 整合DNA较野生型减少:NL4-3-Q148H 5倍(P=0.05),URTR23-Q148H 9倍(P=0.01),ARMA159-Q148H 16000倍(P=0.01)。
  • 互换B与F1(BF)整合酶催化核心结构域200 bp片段未能挽救F1(BF)突变株的复制缺陷。

核心结论

  • F亚型整合酶背景下Q148H的功能损伤解释了该突变通路在BF重组病毒体内未被选择的现象。
  • 整合酶催化核心结构域外的非B亚型多态性可能影响整合酶链转移抑制剂耐药通路的形成。

研究设计与样本

  • 整合酶序列取自Los Alamos数据库或Garrahan HIV队列。
  • 构建含或不含Q148H(+G140S)耐药突变的HIV-1感染性分子克隆,整合酶来源为B亚型NL4-3或F1(BF) ARMA159和URTR23。
  • 通过互换NL4-3-Q148H与ARMA159-Q148H或URTR23-Q148H之间跨越催化核心结构域第85-150位氨基酸的200 bp片段构建整合酶嵌合体。
  • 病毒感染量用p24 ELISA和Alu-gag整合PCR assay定量。

主要发现

  • 至少18个不同多态性区分B亚型与F1(BF)重组整合酶。
  • 感染后第15天p24:野生型和NL4-3-Q148H高(10⁵-10⁶ pg/mL),F1(BF)-Q148H+G140S病毒低(10²-10⁴ pg/mL),Q148H突变株不可测。
  • 整合DNA较野生型减少:NL4-3-Q148H 5倍(P=0.05),URTR23-Q148H 9倍(P=0.01),ARMA159-Q148H 16000倍(P=0.01)。
  • B与F1(BF)间互换整合酶催化核心结构域区域未能挽救F1(BF)整合酶突变株的复制缺陷。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In prior studies, HIV-1 BF recombinants with subtype F integrases failed to develop resistance to raltegravir through the Q148H mutational pathway. We aimed to determine the role of subtype-specific polymorphisms in integrase on drug susceptibility, viral replication and integration. METHODS: Integrase sequences were retrieved from the Los Alamos Database or obtained from the Garrahan HIV cohort. HIV-1 infectious molecular clones with or without Q148H (+ G140S) resistance mutations were constructed using integrases of subtype B (NL4-3) or F1(BF) ARMA159 and URTR23. Integrase chimeras were generated by reciprocal exchanges of a 200 bp fragment spanning amino acids 85-150 of the catalytic core domain (CCD) of NL4-3-Q148H and either ARMA159-Q148H or URTR23-Q148H. Viral infections were quantified by p24 ELISA and Alu-gag integration PCR assay. RESULTS: At least 18 different polymorphisms distinguish subtype B from F1(BF) recombinant integrases. In phenotypic experiments, p24 at Day 15 post-infection was high (105-106 pg/mL) for WT and NL4-3-Q148H; by contrast, it was low (102-104 pg/mL) for both F1(BF)-Q148H + G140S viruses, and undetectable for the Q148H mutants. Compared with WT viruses, integrated DNA was reduced by 5-fold for NL4-3-Q148H (P = 0.05), 9-fold for URTR23-Q148H (P = 0.01) and 16000-fold for ARMA159-Q148H (P = 0.01). Reciprocal exchange between B and F1(BF) of an integrase CCD region failed to rescue the replicative defect of F1(BF) integrase mutants. CONCLUSIONS: The functional impairment of Q148H in the context of subtype F integrases from BF recombinants explains the lack of selection of this pathway in vivo. Non-B polymorphisms external to the integrase CCD may influence the pathway to integrase strand transfer inhibitor resistance.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Aulicino PC, Momin Z, Rozenszajn M, et al. HIV-1 subtype F integrase polymorphisms external to the catalytic core domain contribute to severe loss of replication capacity in context of the integrase inhibitor resistance mutation Q148H. J Antimicrob Chemother. 2022. PMID: 35897124. doi:10.1093/jac/dkac238

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。